Caduet Lawsuit

 

A brief guide to filing a Caduet lawsuit

 

The prescription medication Caduet combines the active ingredients in the medications Lipitor and Norvasc. Three years after its introduction to the market in 2004, manufacturer Pfizer was involved in a high-profile Caduet lawsuit regarding a generic version of the drug. This litigation did not concern potential Caduet side effects and has subsequently been resolved. A generic version of a Caduet dosage has been available since December 2011.

 

The Caduet lawsuit in question was between Pfizer and the company Ranbaxy. Pfizer claimed that manufacturing a generic Caduet dosage would constitute an infringement of its active ingredients. This Caduet lawsuit ultimately resulted in an agreement permitting Ranbaxy to proceed with its plans.

 

Litigation concerning Caduet side effects has not been noted. Though there are some serious potential consequences accompanying treatment with a Caduet dosage, the FDA has not concluded that these justify a severe warning or recalling the product. It is important to develop a comprehensive understanding of Caduet side effects so as to respond promptly and control them.

 

Most of the results of taking a Caduet dosage are not serious. Headaches, dizziness and diarrhea are all commonly reported Caduet side effects. While these responses to treatment with any Caduet dosage should be reported to a physician, they are only serious if they do not decrease in severity as treatment continues.

 

Prescription of the drug is contraindicated in the case of those with liver problems or women who become pregnant. To guard against potential Caduet side effects, a physician may perform a test of your liver function before prescribing a course of treatment with this medication. Some people who are prescribed a Caduet dosage may experience muscle soreness or notice brown or dark urine. These are indications of potential muscular skeletal tissue damage. While rare, such Caduet side effects are serious and can lead to kidney failure or death. Chest pain after taking a Caduet dosage require immediate medical attention, as this may indicative of a heart attack.

 

Such rare incidents have not yet led to a significant Caduet lawsuit. Obtaining compensation relating to serious Caduet side effects may therefore be difficult or impractical for an attorney. Before pursuing a Caduet lawsuit, you should report any adverse effects not noted in prescription information to the FDA. Your case will be taken into consideration if there is a review later of the safety of treatment via Caduet dosage.

 

Litigation regarding Caduet side effects you were not sufficiently warned about must proceed from a foundation of thorough medical documentation. To allow an attorney a chance to provide a trustworthy estimation of the potential success of a Caduet lawsuit, assemble all such papers prior to an initial consultation. Your chances of legal success will increase if studies released in the future demonstrate that your case is not exceptional in its occurrence. Attorneys can draw upon such information to explore the option of a class action Caduet lawsuit representing multiple plaintiffs with the same complaint.

Related Topics